 |
市場調査レポート
商品コード
1473941
研究用抗体と試薬の世界市場規模、シェア、成長分析、技術別、用途別-産業別予測、2024～2031年Global Research Antibodies and Reagents Market Size, Share, Growth Analysis, By Technology(western blotting, flow cytometry), By Application(proteomics, drug development and Genomics) - Industry Forecast 2024-2031 |
||||||
| 研究用抗体と試薬の世界市場規模、シェア、成長分析、技術別、用途別-産業別予測、2024～2031年 |
|
出版日: 2024年04月29日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
研究用抗体と試薬の世界市場規模は、2022年に119億米ドルと評価され、予測期間（2024～2031年）のCAGRは6.70%で、2023年の127億米ドルから2031年には213億3,000万米ドルに成長する展望です。
研究用抗体と試薬は、抗原を対象とする未固定の1次抗体を同定するために使用されます。これらの製品は、免疫組織化学、ウェスタンブロッティング、フローサイトメトリー、ELISAなど様々なプロセスで使用するタンパク質や生体分子の同定、定量、精製に使用できます。研究用抗体と試薬市場の成長を牽引している主要理由の一つは、研究の再現性を高めるために高品質な抗体のニーズが高まっていることです。研究用抗体と試薬市場は、プロテオミクスやゲノミクス研究の成長、診断や治療の全過程を向上させるための研究開発努力の増加により拡大しています。研究用抗体と試薬市場は、神経生物学や幹細胞研究のセグメントの拡大、産学連携の活発化などの影響を受けています。
さらに、研究用抗体と試薬市場は、政府支援の拡大、バイオマーカー開発の重視、営利・非営利組織による研究イニシアティブへの資金提供の増加、アウトソーシングへの関心の高まりなどの恩恵を受けています。研究用抗体と試薬市場参入企業は、新市場、オーダーメイド医療、タンパク質治療に対するニーズの拡大からも恩恵を受けることができます。一方、研究用抗体と試薬市場は、抗体作製プロセスの高コストと期間、大手企業による価格圧力により、市場拡大が抑制されることが予想されます。予測期間を通じて、研究用抗体と試薬市場は、品質への懸念の高まりや再現性の乏しさによって困難に遭遇すると予想されます。
目次
エグゼクティブサマリー
- 市場概要
- 隆盛と衰退
調査手法
- 情報調達
- 二次データソースと一次データソース
- 市場規模の推定
- 市場の危機と限界
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
研究用抗体と試薬の世界市場：技術別
- 市場概要
- ウエスタンブロッティング
- フローサイトメトリー
- ELISA
- 免疫組織化学
- 免疫蛍光
- 免疫沈降法
- その他
研究用抗体と試薬の世界市場：用途別
- 市場概要
- プロテオミクス
- 医薬品開発とゲノミクス
研究用抗体と試薬の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2023年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2023年）
主要企業プロファイル
- Thermo Fisher Scientific, Inc.
- Abcam plc.
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- Cell Signaling Technology, Inc.
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Santa Cruz Biotechnology, Inc.
- GE Healthcare Life Sciences
- BD Biosciences
- BioLegend, Inc.
- R&D Systems, Inc.
- Sigma-Aldrich Corporation
- Lonza Group Ltd.
- Promega Corporation
- Qiagen N.V.
- Affymetrix, Inc.
- Novus Biologicals, LLC
- Enzo Life Sciences, Inc.
- OriGene Technologies, Inc.
Global Research Antibodies and Reagents Market size was valued at USD 11.90 billion in 2022 and is poised to grow from USD 12.70 billion in 2023 to USD 21.33 billion by 2031, at a CAGR of 6.70% during the forecast period (2024-2031).
Research reagents and antibodies are used to identify an unconjugated primary antibody that targets antigen. These products can be used to locate, quantify, and purify proteins or biomolecules for use in various processes such as immunohistochemistry, western blotting, flow cytometry, and ELISA. One of the main reasons driving the growth of the research antibodies and reagents market is the increasing need for high-quality antibodies for research repeatability. The market for research antibodies and reagents is expanding due to the growth of proteomics and genomics research as well as an increase in R&D efforts to enhance the whole course of diagnosis and treatment. The market for research antibodies and reagents is impacted by the expanding disciplines of neurobiology and stem cell research, as well as the increased cooperation between industry and academia.
In addition, the market for research antibodies and reagents benefits from greater government assistance, increased emphasis on biomarker development, increased funding for research initiatives by for-profit and non-profit organizations, and growing interest in outsourcing. Research antibodies and reagents market participants can also benefit from the expanding need for new markets, customized medicine, and protein therapies. On the other hand, it is anticipated that the market for research antibodies and reagents will be restrained in its expansion due to the high cost and duration of the antibody creation processes, as well as pricing pressure from major players. Throughout the forecast period, the market for research antibodies and reagents is anticipated to encounter difficulties due to growing quality concerns and a dearth of repeatable results.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Research Antibodies and Reagents Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Research Antibodies and Reagents Market Segmental Analysis
The research antibodies and reagents market is segmented based on the technology, application and region. Based on technology, research antibodies and reagents market is segmented into western blotting, flow cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and other technologies. Based on application, the Research Antibodies and Reagents Market is segmented into proteomics, drug development and Genomics. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
Drivers of the Global Research Antibodies and Reagents Market
Collaboration between academic institutions and corporate R&D departments is essential for research and innovation. These collaborations ensure that technology and information flow from the commercial sector to academia and vice versa. The growing economic instability and the accelerating speed of technology advancement have led to a significant rise in the number of these kinds of partnerships. Because research-specific antibodies and reagents have so many applications, industry players are focusing on collaborating with academic institutions to raise researcher and student understanding of emerging analytical technologies.
Restraints in the Global Research Antibodies and Reagents Market
Variations in antibody quality are a major cause of the reproducibility challenge, which is the growing realization that many study results in biomedical research cannot be repeated and that conclusions based on them may be unfounded. Variations in antibody production techniques lead to non-reproducible results. There are no universally accepted criteria of repeatability for all antibody offerings, nor validation requirements for them.
Market Trends of the Global Research Antibodies and Reagents Market
By personalized medicine, many diseases are now identified, categorized, and treated differently. This has made personalized medicine a major area of research for the healthcare industry. These advances are especially apparent in oncology. Furthermore, biopharmaceutical companies have nearly quadrupled their research and development (R&D) spending in customized medicine over the last five years; over the next five, this investment is expected to increase by 33%. More than ever, as personalized medicine gets traction and aids in the definition of particular patient treatments, rapid, highly sensitive, and quantitative ways to analyze proteins and related post-translational modifications in clinical specimens are needed. Additionally, researchers are focusing on discovering and comprehending various proteins because gene variants may predict a patient's propensity to respond to a particular medication. Alterations, genetic variants, and the relationships they have with different diseases.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Research Antibodies and Reagents Market by Technology
- Market Overview
- western blotting
- flow cytometry
- ELISA
- Immunohistochemistry
- Immunofluorescence
- Immunoprecipitation
- and other technologies
Global Research Antibodies and Reagents Market by Application
- Market Overview
- proteomics
- drug development and Genomics
Global Research Antibodies and Reagents Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2023
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2023
Key Company Profiles
- Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Santa Cruz Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BD Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLegend, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- R&D Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sigma-Aldrich Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lonza Group Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Affymetrix, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novus Biologicals, LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Life Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
